• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性感染与耐药性感染:探讨生物膜在临床实践中的潜在作用

Recurring and antimicrobial-resistant infections:considering the potential role of biofilms in clinical practice.

作者信息

Saye Donald E

出版信息

Ostomy Wound Manage. 2007 Apr;53(4):46-8, 50, 52 passim.

PMID:17449916
Abstract

Micro-organisms commonly produce biofilm, a polymeric matrix that is adherent to inert or living substances and frequently forms on environmental surfaces, medical devices, and traumatized or compromised living and nonviable necrotic tissues such as wounds. The micro-organisms in a biofilm interact with each other and their environment. They are refractory to conventional therapy and resist conventional methods for culturing; their coordinated activities can lessen the effect of antimicrobials and the host's defenses. The multifactorial mechanism of resistance varies and depends, in part, on the strain of the micro-organism. A biofilm is dynamic and may shed bacteria or bacteria may be released by trauma, resulting in local or systemic infectious disease. Released bacteria lose their protection - they become responsive to appropriate levels of antimicrobials and may be cultured using conventional culturing methods. Micro-organisms in biofilms may remain dormant for weeks or years before causing local or systemic signs and symptoms of infection and are commonly responsible for recurring infections after repeated trials of antibiotics. Most biofilm infection-related research findings have not reached clinical practice yet. However, clinician knowledge about the development of and difficulties culturing micro-organisms in biofilms and their resistance to antibiotics and biocides may lead to improved clinical outcomes in soft tissue and bone infections and the treatment of wounds.

摘要

微生物通常会产生生物膜,这是一种聚合基质,可附着于惰性物质或生物物质上,且经常在环境表面、医疗设备以及创伤或受损的活体和无活力坏死组织(如伤口)上形成。生物膜中的微生物相互之间以及与它们的环境相互作用。它们对传统疗法具有抗性,并且难以用传统培养方法培养;它们的协同活动会降低抗菌药物和宿主防御的效果。抗性的多因素机制各不相同,部分取决于微生物的菌株。生物膜是动态的,可能会脱落细菌,或者细菌可能因创伤而释放,从而导致局部或全身性传染病。释放出的细菌失去了保护——它们会对抗菌药物的适当剂量产生反应,并且可以用传统培养方法进行培养。生物膜中的微生物在引起局部或全身性感染体征和症状之前可能会休眠数周或数年,并且通常是反复使用抗生素治疗后反复感染的原因。大多数与生物膜感染相关的研究结果尚未应用于临床实践。然而,临床医生对生物膜中微生物的形成、培养困难以及它们对抗生素和杀菌剂的抗性的了解,可能会改善软组织和骨感染以及伤口治疗的临床结果。

相似文献

1
Recurring and antimicrobial-resistant infections:considering the potential role of biofilms in clinical practice.复发性感染与耐药性感染:探讨生物膜在临床实践中的潜在作用
Ostomy Wound Manage. 2007 Apr;53(4):46-8, 50, 52 passim.
2
Biofilms on medical devices.医疗器械上的生物膜
Home Healthc Nurse. 2007 Oct;25(9):589-94. doi: 10.1097/01.NHH.0000296117.87061.14.
3
Clinical experience with wound biofilm and management: a case series.伤口生物膜及其处理的临床经验:病例系列
Ostomy Wound Manage. 2009 Apr;55(4):38-49.
4
Topical antimicrobials in the control of wound bioburden.用于控制伤口生物负荷的局部抗菌剂。
Ostomy Wound Manage. 2006 Aug;52(8):26-58.
5
Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?生物膜与抗生素治疗:新型药物递送系统在对抗细菌耐药性方面是否发挥作用?
Adv Drug Deliv Rev. 2005 Jul 29;57(10):1539-50. doi: 10.1016/j.addr.2005.04.007.
6
Effect of antibacterials on biofilms.抗菌药物对生物被膜的影响。
Am J Infect Control. 2008 Dec;36(10):S175.e9-11. doi: 10.1016/j.ajic.2008.10.002.
7
Quorum sensing in biofilms--how to destroy the bacterial citadels or their cohesion/power?生物膜中的群体感应——如何摧毁细菌的城堡或它们的凝聚力/力量?
Anaerobe. 2011 Dec;17(6):280-5. doi: 10.1016/j.anaerobe.2011.03.023. Epub 2011 Apr 8.
8
Immunology, microbiology, and the recalcitrant wound.免疫学、微生物学与顽固性伤口
Ostomy Wound Manage. 2000 Jan;46(1A Suppl):77S-82S; quiz 83S-84S.
9
Bacterial biofilms within the clinical setting: what healthcare professionals should know.临床环境中的细菌生物膜:医护人员应了解的知识。
J Hosp Infect. 2006 Dec;64(4):313-25. doi: 10.1016/j.jhin.2006.06.028.
10
The physiology and collective recalcitrance of microbial biofilm communities.微生物生物膜群落的生理学及集体抗性
Adv Microb Physiol. 2002;46:202-56.

引用本文的文献

1
Frequently Touched Sites in the Intensive Care Unit Environment Returning 100 Colony-Forming Units per Surface Area Sampled Are Associated With Increased Risk of Major Bacterial Pathogen Detection.重症监护病房环境中每采样表面积返回100个菌落形成单位的频繁接触部位与检测到主要细菌病原体的风险增加相关。
Cureus. 2024 Aug 31;16(8):e68317. doi: 10.7759/cureus.68317. eCollection 2024 Aug.
2
Baicalin acts as an adjuvant to potentiate the activity of azithromycin against Staphylococcus saprophyticus biofilm: an in vitro, in vivo, and molecular study.黄芩苷作为佐剂增强阿奇霉素对腐生葡萄球菌生物膜活性的作用:体外、体内和分子研究。
Vet Res. 2022 Oct 12;53(1):83. doi: 10.1186/s13567-022-01088-z.
3
efficacy of a unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by .
一种独特的一流抗生物膜抗生素对由……引起的生物膜相关伤口感染的疗效。
Biofilm. 2020 Jul 17;2:100032. doi: 10.1016/j.bioflm.2020.100032. eCollection 2020 Dec.
4
CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.CD101,一种新型棘白菌素,对早期和成熟白色念珠菌生物膜具有强大的抗生物膜活性。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01750-17. Print 2018 Feb.
5
Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms.工程肽与抗生素对铜绿假单胞菌生物膜的单独及联合作用
Pharmaceuticals (Basel). 2017 Jun 25;10(3):58. doi: 10.3390/ph10030058.
6
In Vitro Efficacy of Nonantibiotic Treatments on Biofilm Disruption of Gram-Negative Pathogens and an In Vivo Model of Infectious Endometritis Utilizing Isolates from the Equine Uterus.非抗生素治疗对革兰氏阴性病原菌生物膜破坏的体外疗效以及利用马子宫分离株建立的感染性子宫内膜炎体内模型
J Clin Microbiol. 2016 Mar;54(3):631-9. doi: 10.1128/JCM.02861-15. Epub 2015 Dec 30.
7
[Effects of Yili dark bee propolis on oral cariogenic biofilm in vitro].[伊犁黑蜂蜂胶对体外口腔致龋生物膜的影响]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2015 Aug;33(4):343-6. doi: 10.7518/hxkq.2015.04.004.
8
Small lipopeptides possess anti-biofilm capability comparable to daptomycin and vancomycin.小型脂肽具有与达托霉素和万古霉素相当的抗生物膜能力。
RSC Adv. 2015;5(73):59758-59769. doi: 10.1039/C5RA07896B.
9
A Novel Qualitative and Quantitative Biofilm Assay Based on 3D Soft Tissue.一种基于三维软组织的新型定性和定量生物膜检测方法。
Int J Biomater. 2014;2014:768136. doi: 10.1155/2014/768136. Epub 2014 Feb 18.
10
Special considerations in the management of osteomyelitis defects (diabetes, the ischemic or dysvascular bed, and irradiation).骨髓炎缺损治疗的特殊注意事项(糖尿病、缺血或血运不良床和放疗)。
Semin Plast Surg. 2009 May;23(2):132-40. doi: 10.1055/s-0029-1214165.